<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JKOS</journal-id>
<journal-title-group>
<journal-title>Journal of the Korean Ophthalmological Society</journal-title>
<abbrev-journal-title>J Korean Ophthalmol Soc</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0378-6471</issn>
<issn pub-type="epub">2092-9374</issn>
<publisher>
<publisher-name>Korean Ophthalmological Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3341/jkos.2016.57.6.1012</article-id>
<article-id pub-id-type="publisher-id">jkos-57-1012</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Bilateral Simultaneous Central Retinal Vein Occlusion in a Patient with Waldenstrom&#x0027;s Macroglobulinemia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Sang Eon</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Shin</surname><given-names>Yong Un</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Lim</surname><given-names>Han Woong</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Seong</surname><given-names>Min Chul</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Cho</surname><given-names>Hee Yoon</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Kang</surname><given-names>Min Ho</given-names></name>
<degrees>MD</degrees>
<xref ref-type="corresp" rid="c1-jkos-57-1012"/>
<xref ref-type="aff" rid="aff1-jkos-57-1012"/>
</contrib>
<aff id="aff1-jkos-57-1012">Department of Ophthalmology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-jkos-57-1012">Address reprint requests to <bold>Min Ho Kang, MD</bold> Department of Ophthalmology, Hanyang University Guri Hospital, &#x0023;153 Gyeongchun-ro, Guri 11923, Korea Tel: 82-31-560-2350, Fax: 82-31-564-9479 E-mail: <email>ocularimmunity@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>09</month>
<year>2016</year>
</pub-date>
<volume>57</volume><issue>6</issue>
<fpage>1012</fpage>
<lpage>1017</lpage>
<history>
<date date-type="received"><day>10</day><month>07</month><year>2015</year></date>
<date date-type="rev-recd"><day>19</day><month>09</month><year>2015</year></date>
<date date-type="accepted"><day>14</day><month>11</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016 Korean Ophthalmological Society</copyright-statement>
<copyright-year>2016</copyright-year>
<license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<sec>
<title>Purpose</title>
<p>The authors report a case of bilateral simultaneous central retinal vein occlusion caused by Waldenstrom&#x0027;s macroglobulinemia.</p>
</sec>
<sec><title>Case summary</title>
<p>A 65-year-old man presented to our department complaining of decreased visual acuity for the duration of about 6 months. On his initial visit, best-corrected visual acuity was 0.02 in the right eye and 0.06 in the left eye. Based on the findings of a funduscopic examination, the patient had bilateral diffuse retinal hemorrhages, dilated tortuous veins, and macular edema. He had experienced recurrent spontaneous epistaxis 6 months previously and had undergone treatments such as intravitreal bevacizumab injection and intravitreal dexamethasone implantation at another hospital. Laboratory tests at that hospital showed anemia and hyperproteinemia, for which he was referred to our hemato-oncology department. Bone marrow biopsy was consistent with Waldenstrom&#x0027;s macroglobulinemia/lymphoplasmacytoid lymphoma, and he was treated with systemic chemotherapy. One year after the systemic chemotherapy, his best-corrected visual acuity was 0.15 in the right eye and 0.6 in the left eye. Funduscopy showed decreased bilateral retinal hemorrhages and macular edema.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>When simultaneous bilateral central retinal vein occlusion occurs in a patient with no other underlying disease such as hypertension or diabetes, it might be a sign of serum hyperviscosity, and there should be a very high level of suspicion for presence or progression of systemic disease. If such a disease is properly and timely diagnosed, effective early systemic evaluation and therapy can be administered, and it is important to have initial general treatment as well as ophthalmic treatment.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<kwd>Central retinal vein occlusion</kwd>
<kwd>Waldenstrom&#x0027;s</kwd>
<kwd>macroglobulinemia</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list>
<title>References</title>
<ref id="b1-jkos-57-1012"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahey</surname> <given-names>JM</given-names></name> <name><surname>Tun&#x00E7;</surname> <given-names>M</given-names></name> <name><surname>Kearney</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Laboratory evaluation of abdominal states in patients with central retinal vein occlusion who are less than 56 years of age</article-title> <source>Ophthalmology</source> <year>2002</year> <volume>109</volume><fpage>126</fpage><lpage>31</lpage></element-citation></ref>
<ref id="b2-jkos-57-1012"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prisco</surname> <given-names>D</given-names></name> <name><surname>Marcucci</surname> <given-names>R</given-names></name></person-group> <article-title>Retinal vein thrombosis: risk factors, abdominal and therapeutic approach</article-title> <source>Pathophysiol Haemost Thromb</source> <year>2002</year> <volume>32</volume><fpage>308</fpage><lpage>11</lpage></element-citation></ref>
<ref id="b3-jkos-57-1012"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname> <given-names>J</given-names></name> <name><surname>Singhal</surname> <given-names>S</given-names></name></person-group> <article-title>Hyperviscosity syndrome in plasma cell dyscrasias</article-title> <source>Semin Thromb Hemost</source> <year>2003</year> <volume>29</volume><fpage>467</fpage><lpage>71</lpage></element-citation></ref>
<ref id="b4-jkos-57-1012"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>KI</given-names></name> <name><surname>Yum</surname> <given-names>HR</given-names></name> <name><surname>Kim</surname> <given-names>IT</given-names></name></person-group> <article-title>Bilateral central retinal vein occlusion in patient with disseminated intravascular coagulation</article-title> <source>J Korean Ophthalmol Soc</source> <year>2011</year> <volume>52</volume><fpage>1005</fpage><lpage>8</lpage></element-citation></ref>
<ref id="b5-jkos-57-1012"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gertz</surname> <given-names>MA</given-names></name></person-group> <article-title>Waldenstr&#x00F6;m macroglobulinemia: a review of therapy</article-title> <source>Am J Hematol</source> <year>2005</year> <volume>79</volume><fpage>147</fpage><lpage>57</lpage></element-citation></ref>
<ref id="b6-jkos-57-1012"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldenstr&#x00F6;m</surname> <given-names>J</given-names></name></person-group> <article-title>Incipient myelomatosis or &#x00AB;essential&#x00AB; hyper-globulinemia with fibrinogenopenia &#x2013; a new syndrome?</article-title> <source>Acta Medica Scandinavica</source> <year>1944</year> <volume>117</volume><fpage>216</fpage><lpage>47</lpage></element-citation></ref>
<ref id="b7-jkos-57-1012"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casares</surname> <given-names>PZ</given-names></name> <name><surname>Gillet</surname> <given-names>DS</given-names></name> <name><surname>Verity</surname> <given-names>DH</given-names></name> <name><surname>Rowson</surname> <given-names>NR</given-names></name></person-group> <article-title>Bilateral abdominal central retinal vein occlusion (CRVO) caused by waldenstrom&#x0027;s macroglobulinaemia with acquired von willebrand&#x0027;s disease</article-title> <source>Br J Haematol</source> <year>2002</year> <volume>118</volume><fpage>344</fpage><lpage>7</lpage></element-citation></ref>
<ref id="b8-jkos-57-1012"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>P</given-names></name> <name><surname>Flanagan</surname> <given-names>D</given-names></name> <name><surname>Reqe</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>Bilateral simultaneous central retinal vein occlusion secondary to hyperviscosity in abdominal&#x0027;s macroglobulinaemia</article-title> <source>Eye (Lond)</source> <year>2008</year> <volume>22</volume><fpage>1089</fpage><lpage>92</lpage></element-citation></ref>
<ref id="b9-jkos-57-1012"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>YH</given-names></name> <name><surname>Lee</surname> <given-names>JY</given-names></name> <name><surname>Kim</surname> <given-names>YS</given-names></name> <etal/></person-group> <article-title>Successful anticoagulation for abdominal central retinal vein occlusions accompanied by cerebral abdominal thrombosis</article-title> <source>Arch Neurol</source> <year>2006</year> <volume>63</volume><fpage>1648</fpage><lpage>51</lpage></element-citation></ref>
<ref id="b10-jkos-57-1012"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>PS</given-names></name> <name><surname>Garg</surname> <given-names>SJ</given-names></name> <name><surname>Fineman</surname> <given-names>MS</given-names></name> <etal/></person-group> <article-title>Serous macular detachment in Waldenstr&#x00F6;m macroglobulinemia: a report of four cases</article-title> <source>Am J Ophthalmol</source> <year>2013</year> <volume>155</volume><fpage>448</fpage><lpage>55</lpage></element-citation></ref>
<ref id="b11-jkos-57-1012"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caimi</surname> <given-names>A</given-names></name> <name><surname>Giani</surname> <given-names>A</given-names></name> <name><surname>Bottoni</surname> <given-names>F</given-names></name> <name><surname>Staurenghi</surname> <given-names>G</given-names></name></person-group> <article-title>Serous macular abdominal in Waldenstr&#x00F6;m macroglobulinemia: a report of 4 cases</article-title> <source>Am J Ophthalmol</source> <year>2013</year> <volume>155</volume><fpage>955</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b12-jkos-57-1012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenicia</surname> <given-names>V</given-names></name> <name><surname>Balestrieri</surname> <given-names>M</given-names></name> <name><surname>Perdicchi</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Intravitreal injection of dexamethasone implant in serous macular detachment associated with Waldenstr&#x00F6;m&#x0027;s disease</article-title> <source>Case Rep Ophthalmol</source> <year>2013</year> <volume>4</volume><fpage>64</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b13-jkos-57-1012"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besirli</surname> <given-names>CG</given-names></name> <name><surname>Johnson</surname> <given-names>MW</given-names></name></person-group> <article-title>Immunogammopathy maculopathy abdominal with Waldenstr&#x00F6;m macroglobulinemia is refractory to conventional interventions for macular edema</article-title> <source>Retin Cases Brief Rep</source> <year>2013</year> <volume>7</volume><fpage>319</fpage><lpage>24</lpage></element-citation></ref>
<ref id="b14-jkos-57-1012"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menke</surname> <given-names>MN</given-names></name> <name><surname>Feke</surname> <given-names>GT</given-names></name> <name><surname>McMeel</surname> <given-names>JW</given-names></name> <name><surname>Treon</surname> <given-names>SP</given-names></name></person-group> <article-title>Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom&#x0027;s macroglobulinemia</article-title> <source>Invest Ophthalmol Vis Sci</source> <year>2008</year> <volume>49</volume><fpage>1157</fpage><lpage>60</lpage></element-citation></ref>
<ref id="b15-jkos-57-1012"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratanam</surname> <given-names>M</given-names></name> <name><surname>Ngim</surname> <given-names>YS</given-names></name> <name><surname>Khalidin</surname> <given-names>N</given-names></name> <name><surname>Subrayan</surname> <given-names>V</given-names></name></person-group> <article-title>Intravitreal abdominal: a viable treatment for bilateral central retinal vein abdominal with serous macular detachment secondary to Waldenstr&#x00F6;m macroglobulinaemia</article-title> <source>Br J Haematol</source> <year>2015</year> <volume>170</volume><fpage>431</fpage><lpage>4</lpage></element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-jkos-57-1012" position="anchor">
<label>Figure 1.</label>
<caption xml:lang="en"><p>Fundus photographs when his first visit. Fundus photographs show dilated tortuous veins, diffuse retinal hemorrhages in all quadrants and vascular sheathing in the right eye (A) and left eye (B).</p></caption>
<graphic xlink:href="jkos-57-1012f1.tif"/>
</fig>
<fig id="f2-jkos-57-1012" position="anchor">
<label>Figure 2.</label>
<caption xml:lang="en"><p>Optical coherence tomography (OCT) finding when his first visit. OCT shows macular edema in the both eyes and more severe subretinal fluid in the right eye (A) than in the left eye (B). OD &#x003D; oculus dexter; OS &#x003D; oculus sinister; R &#x003D; right; L &#x003D; left; ILM &#x003D; internal limiting membrane; RPE &#x003D; retinal pigment epithelium; ETDRS &#x003D; Early Treatment Diabetic Retinopathy Study; S &#x003D; superior; N &#x003D; nasal; I &#x003D; inferior; T &#x003D; temporal.</p></caption>
<graphic xlink:href="jkos-57-1012f2.tif"/>
</fig>
<fig id="f3-jkos-57-1012" position="anchor">
<label>Figure 3.</label>
<caption xml:lang="en"><p>Fundus photographs after the systemic chemotherapy. Fundus photographs show decreased dilated tortuous veins and retinal hemorrhages in the both eyes and decreased vascular sheathing in the right eye. There are few changes between 3 months (A, B) and 1 year (C, D).</p></caption>
<graphic xlink:href="jkos-57-1012f3.tif"/>
</fig>
<fig id="f4-jkos-57-1012" position="anchor">
<label>Figure 4.</label>
<caption xml:lang="en"><p>Optical coherence tomography (OCT) finding after the systemic chemotherapy. OCT shows decreased subretinal fluid and macular edema in the right eye (A) and the left eye (B). But, subretinal fluid and macular edema still remains. Subretinal fibrin accumulation or choroid neovascularization are not detected due to serous retinal detachment. OCT shows atrophy of the retinal pigment epithelium on the macula and decrease in outer neuroretina layer thickness. OD &#x003D; oculus dexter; OS &#x003D; oculus sinister; R &#x003D; right; L &#x003D; left; T &#x003D; temporal; N &#x003D; nasal; S &#x003D; superior.</p></caption>
<graphic xlink:href="jkos-57-1012f4.tif"/>
</fig>
</sec>
</back>
</article>
